SPL-410

N/A

Report date: 2023/01/01 20:06:10
NME

Base Information

Drug NameSPL-410
Drug Alias NameSPL-410
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSoluble Fas ligand inhibitors
TargetsSoluble Fas ligand
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A